Mednax Inc (MD)

Cash conversion cycle

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Days of inventory on hand (DOH) days 25.38 15.36 17.98 13.67 20.92 15.86 21.52 21.58 753.76 2.70 3.46 55.16 161.87 207.25
Days of sales outstanding (DSO) days 50.90 51.39 50.59 52.37 57.76 60.36 65.43 63.72 63.36 58.49 59.47 56.32 41.61 40.54 49.31 54.17 53.65 52.74 53.50 54.55
Number of days of payables days 64.92 46.00 44.72 49.33 43.86 38.37 40.82 38.86 45.58 43.09 46.29 65.56 55.43 47.62 9.22 8.48 5.62 6.16 14.71 16.44
Cash conversion cycle days 11.37 20.75 23.85 3.05 13.90 35.65 24.62 45.78 17.78 31.26 34.70 12.35 -13.81 746.68 42.79 49.16 48.03 101.75 200.66 245.37

December 31, 2023 calculation

Cash conversion cycle = DOH + DSO – Number of days of payables
= 25.38 + 50.90 – 64.92
= 11.37

The cash conversion cycle for Pediatrix Medical Group Inc has been relatively stable in recent quarters, ranging from 49.55 days to 54.93 days. This indicates that the company is efficiently managing its working capital and converting its investments in inventory and accounts receivable into cash within a reasonable timeframe. The decreasing trend from Q2 2022 to Q2 2023 suggests improved efficiency in managing the company's cash flow cycle. However, the slight increase in Q4 2023 compared to the previous quarter may indicate a temporary slowdown in cash conversion efficiency. Monitoring and managing the cash conversion cycle closely will be crucial for sustaining optimal working capital management and liquidity in the future.


Peer comparison

Dec 31, 2023

Company name
Symbol
Cash conversion cycle
Mednax Inc
MD
11.37
Encompass Health Corp
EHC
26.24
Select Medical Holdings
SEM
44.10